Replies to post #377665 on Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

I think the shareholder deficit was something in the $100M area a few quarters ago. We were discussing it for taxation purposes but never got far.

I can't be bothered to check the current 10Q but it's likely in the $110-130M area now.

Only reinforces the point about the $1B buyout. $110M in, $1000M out is a pretty good return even over 9 years.

Few would fault Leo for cashing out on that.

Go IPIX!

[L vus]

Question for you sir. Money is needed for nebulizer research and IPIX has to partner with a BP to retain Brilacidin for the future potential as well as the here and now. It would be unthinkable for Leo to sell.

[loanranger]

I don't think there's a need to spitball. As noted the accumulated deficit at 6/30/21 was $115M but Stockholders Equity (raised but NOT lost) was $8M so ballpark $123M was raised, not $400 million invested or closer to 200 to 300 million.

The original statement is what got my attention:
"There’s nothing wrong with 2.50 a share for a company with $400 million invested and currently trading at 1/12th the price."

How much a suitor might spend on an acquisition has nothing to do with how much the candidate raised, especially if it only has a teeny weeny bit of it left. Other metrics having to do with estimated future income and resultant cash flows are the primary drivers of the price.